| Literature DB >> 35524552 |
Kathleen Gallo1, Andrean Goede1, Robert Preissner1, Bjoern-Oliver Gohlke1.
Abstract
Since the last published update in 2014, the SuperPred webserver has been continuously developed to offer state-of-the-art models for drug classification according to ATC classes and target prediction. For the first time, a thoroughly filtered ATC dataset, that is suitable for accurate predictions, is provided along with detailed information on the achieved predictions. This aims to overcome the challenges in comparing different published prediction methods, since performance can vary greatly depending on the training dataset used. Additionally, both ATC and target prediction have been reworked and are now based on machine learning models instead of overall structural similarity, stressing the importance of functional groups for the mechanism of action of small molecule substances. Additionally, the dataset for the target prediction has been extensively filtered and is no longer only based on confirmed binders but also includes non-binding substances to reduce false positives. Using these methods, accuracy for the ATC prediction could be increased by almost 5% to 80.5% compared to the previous version, and additionally the scoring function now offers values which are easily assessable at first glance. SuperPred 3.0 is publicly available without the need for registration at: https://prediction.charite.de/index.php.Entities:
Year: 2022 PMID: 35524552 PMCID: PMC9252837 DOI: 10.1093/nar/gkac297
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 19.160
Figure 1.Overview of the accuracies for the different target prediction models, evaluated via 10-fold cross-validation.
Comparison of the accuracy of different ATC prediction servers. * = accuracy for expected ATC code reported as first hit evaluated from AUC figure, ** = using SuperPred 2.0 dataset, *** = using SuperPred 3.0 dataset
| Publication | Level 1 accuracy [%] | Level 4 accuracy [%] | Webserver |
|---|---|---|---|
| Olson, 2017 | 73.7 | 41.2 | No |
| Cheng, 2017 | 67.1 | - | No |
| Lumini, 2018 | 77.8 | - | No |
| Wang, 2019 | 79.5 | - | No |
| Peng, 2021 | - | 33* | Not reachable |
| SuperPred 2.0 | 80.9 | 75.1 | - |
| SuperPred 3.0 | 87.9**/82.3*** | 80.5**/70.1*** | Yes |
Figure 2.Computational output for ATC and target prediction of the substance levonadifloxacin.